The research interests of Lizhi Zhang, M.D., focus on pancreatic cancer, pancreatic neuroendocrine tumor, autoimmune pancreatitis and other pancreatic diseases. Dr. Zhang has expertise using clinical, molecular and genomic tools to conduct translational studies to understand pancreatic pathology. Dr. Zhang leads the Mayo Clinic Pancreatic Cancer SPORE Tissue Core, which provides biospecimens for use in pancreatic cancer trials.
- Pancreatic cancer
- Prognostic markers of pancreatic cancer and pancreatic neuroendocrine tumor
- Clinical and pathological features of type 1 and type 2 autoimmune pancreatitis
- Genetic features of benign and metastatic solid pseudopapillary tumor
- Genetic abnormalities of pancreatoblastoma
Significance to patient care
Through detailed morphological and genetic analysis, Dr. Zhang aims to provide useful information related to the diagnosis, therapeutic targets and prognosis of pancreatic diseases.
- Director, Pancreatic SPORE Tissue Core, Mayo Clinic, 2019-present
- President, The International Association of Chinese Pathologists, 2015
- Recipient, Stowell-Orbison Award, United States & Canadian Academy of Pathology, 2009
- Recipient, GIPS Abstract Award, Rodger C. Haggitt Gastrointestinal Pathology Society (GIPS), 2006